New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time

University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new approach to treating recurrent brain tumors. GammaTile Therapy is a U.S. Food and Drug Administration (FDA)-cleared, surgically targeted radiation therapy (STaRT) manufactured by GT Medical Technologies that is designed to delay tumor regrowth for patients with brain tumors. The first patient was treated by University of Minnesota physician Clark C. Chen, M.D., Ph.D., head...

from A via a.sfakia on Inoreader https://ift.tt/2Iu62si